Myosin VI Antikörper (N-Term)
-
- Target Alle Myosin VI (MYO6) Antikörper anzeigen
- Myosin VI (MYO6)
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Myosin VI Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Kreuzreaktivität
- Human, Maus, Ratte
- Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from the N-terminal region of Human Myosin VI.
- Isotyp
- IgG
- Top Product
- Discover our top product MYO6 Primärantikörper
-
anti-Myosin VI (MYO6) (N-Term) antibody
MYO6 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Myosin VI (MYO6) (AA 1166-1195), (C-Term) antibodyMYO6 Reaktivität: Human WB, IF, IHC (p) Wirt: Kaninchen Polyclonal RB19127 unconjugated
anti-Myosin VI (MYO6) antibodyMYO6 Reaktivität: Human, Maus, Ratte WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Myosin VI (MYO6) (AA 1188-1285) antibodyMYO6 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2E12 unconjugated
anti-Myosin VI (MYO6) (AA 1173-1203), (C-Term) antibodyMYO6 Reaktivität: Human WB, IF, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Myosin VI (MYO6) (AA 1016-1285) antibodyMYO6 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB:1:500-1:2000, ELISA:1:5000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- Myosin VI (MYO6)
- Andere Bezeichnung
- MYO6 (MYO6 Produkte)
- Synonyme
- 95F antikoerper, 95F MHC antikoerper, CG5695 antikoerper, Dm 95F antikoerper, Dm95F antikoerper, Dmel\\CG5695 antikoerper, Dro95F antikoerper, JAG antikoerper, Jaguar antikoerper, Jar antikoerper, M6 antikoerper, MHC95F antikoerper, MYOVI antikoerper, Mhc95F antikoerper, MyoVI antikoerper, Myosin VI antikoerper, jag antikoerper, ms(3)06746 antikoerper, myosins VI antikoerper, DFNA22 antikoerper, DFNB37 antikoerper, BC029719 antikoerper, Tlc antikoerper, sv antikoerper, RGD1560646 antikoerper, CMY6 antikoerper, jaguar antikoerper, myosin VI antikoerper, jar antikoerper, LOC373230 antikoerper, MYO6 antikoerper, myo6 antikoerper, Myo6 antikoerper
- Hintergrund
- Deafness autosomal recessive 37 antibody, DFNA 22 antibody, DFNA22 antibody, DFNB 37 antibody, DFNB37 antibody, KIAA0389 antibody, MYO 6 antibody, Myo6 antibody, MYO6_HUMAN antibody, Myosin VI antibody, Myosin-VI antibody, Myosin6 antibody, Unconventional myosin-6 antibody, Unconventional myosin-VI antibody
- UniProt
- Q9UM54
- Pathways
- Sensory Perception of Sound, Dicarboxylic Acid Transport, Asymmetric Protein Localization
-
